BOTHELL, Wash., March 9 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. , a leader in developing therapeutics using advanced molecular biology-based drug delivery technologies, announced today that its fourth quarter and full year 2005 financial results will be released on Thursday, March 16, 2006 after the Nasdaq National Market System closes. Management will host a conference call with investors and financial analysts to discuss these results and to provide an update of the Company’s clinical pipeline at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).
To participate in the live conference call, U.S. residents should dial (866) 770-7129 and international callers should dial (617) 213-8067. The access code for the live conference call is 88696879. To access the 24-hour telephone replay, U.S. residents should dial (888) 286-8010 and international callers should dial (617) 801-6888. The access code for the replay is 96330460.
Alternatively, to access the live audio webcast for this conference call or the subsequent 30-day archive, please log on to Nastech’s website at http://www.nastech.com approximately 15 minutes prior to the conference call in order to register and download any necessary software.
About Nastech
We are a pharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. We and our collaboration partners are developing products for multiple therapeutic areas including osteoporosis, obesity, respiratory disease and inflammatory conditions. Additional information about Nastech is available at http://www.nastech.com.
CONTACTS: Nastech Pharmaceutical Company Inc. Ed Bell Senior Investor Relations Manager (425) 908-3639 ir@nastech.com Noonan Russo Matthew Haines (Investors/Media) (212) 845-4235
Nastech Pharmaceutical Company Inc.
CONTACT: Ed Bell, Senior Investor Relations Manager of NastechPharmaceutical Company Inc., +1-425-908-3639, ir@nastech.com; orInvestors-Media: Matthew Haines of Noonan Russo, +1-212-845-4235, forNastech Pharmaceutical Company
Web site: http://www.nastech.com/
